English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduArticle title: Sex differences in cardiovascular disease and dysregulation in Down syndrome Authors: Melissa L. Bates, Anastasiia Vasileva, Laura D.M. Flores, Yana Pryakhina, Michelle Buckman, Michael H. Tomasson, Lara R. DeRuisseau From the authors: “Based on the results of our…
Tag: Heart Disease
TCT 2023 Career Achievement Award to be Presented to Stuart J. Pocock, PhD
The TCT 2023 Career Achievement Award will be presented to Stuart J. Pocock, PhD, during Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation (CRF). TCT will take place October 23-26, 2023, in San Francisco at the Moscone Center. The award is given each year to an outstanding individual who has made significant contributions to the field of interventional cardiology and transformed patient care through their career endeavors, research pursuits, and mentorship.
A Registered Dietitian’s Reaction to the New FDA Proposed Rule on Salt
According to the American Heart Association, roughly 90% of Americans are overdoing it on salt, consuming over twice the daily recommended amount. The U.S. Food and Drug Administration (FDA) announced recently it was proposing a rule to allow the use of salt…
Genetic tests unexpectedly find genes linked to heart disease — now what?
As health care professionals, researchers and consumers increasingly use genetic testing, they are uncovering incidental genetic abnormalities, or variants, that are associated with cardiovascular diseases.
The heart benefits of walnuts likely come from the gut
A new study examining the gene expression of gut microbes suggests that the heart-healthy benefits of walnuts may be linked to beneficial changes in the mix of microbes found in our gut.
Media Registration for TCT 2023 Now Open
Media registration is now open for TCT 2023 (Transcatheter Cardiovascular Therapeutics), the annual scientific symposium of the Cardiovascular Research Foundation (CRF). TCT is the world’s premier educational meeting specializing in interventional cardiovascular medicine. TCT, which will be held October 23-26, 2023 in San Francisco, California at the Moscone Center, will be celebrating 35 years of leading the field.
U-CARS 2023: Healing Diseased Hearts, from Bench to Bedside
Now in its 11th year, participants in Utah Cardiac Recovery Symposium (U-CARS) will exchange ideas and evaluate paradigms on a now-thriving field of science and medicine that was once thought to be impossible: making diseased hearts healthy again.
University of Utah and TikkunLev Therapeutics announce new partnership to accelerate heart-failure gene therapy
The new partnership aims to accelerate an innovative heart-failure gene therapy. The agreement is an exclusive world-wide license and includes a sponsored research program to support future FDA filings.
Heart Tissue Heads to Space to Aid Research on Aging and Impact of Long Spaceflights
Johns Hopkins Medicine researchers are collaborating with NASA to send human heart “tissue-on-a-chip” specimens into space as early as March. The project is designed to monitor the tissue for changes in heart muscle cells’ mitochondria (their power supply) and ability to contract in low-gravity conditions.
Chula’s AICute Innovation – An Assessment Tool for Ischemic Stroke Risk to Reduce Disability and Death
A research team from the Faculty of Medicine and Faculty of Engineering, Chulalongkorn University has jointly developed AICute, an innovative program to assess the chances of stroke caused by heart disease (Ischemic Stroke), aimed at helping hospitals that lack cardiologists to enhance the effectiveness of stroke treatment, reduce congestion in hospitals and medical schools.
Microvascular Impairment Caused by Chronic Estrogen Exposure Is Sex-specific
Article title: 17β-estradiol promotes sex-specific dysfunction in isolated human arterioles Authors: Gopika SenthilKumar, Boran Katunaric, Henry Bordas-Murphy, Micaela Young, Erin L. Doren, Mary E. Schulz, Michael E. Widlansky, Julie K. Freed From the authors: “To our knowledge, this is the…
THT 2023 Late-Breaking Clinical Science Announced
The full list of late-breaking clinical science to be presented at THT 2023: Technology and Heart Failure Therapeutics is now available online. An international heart failure conference organized by the Cardiovascular Research Foundation (CRF), THT will take place March 20-22, 2023, at the Westin Boston Seaport in Boston, MA.
Rutgers Researchers Use Artificial Intelligence to Predict Cardiovascular Disease
According to a new study from Rutgers Institute for Health, researchers may be able to predict cardiovascular disease in patients by using artificial intelligence to examine the genes in their DNA.
TCT 2023 Master Operator Award to Be Presented to William L. Lombardi, MD
The TCT Geoffrey O. Hartzler Master Operator Award will be presented to William L. Lombardi, MD during Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation (CRF). TCT will take place October 23-26, 2023, in San Francisco at the Moscone Center. The award is given each year to a physician who has advanced the field of interventional cardiovascular medicine through technical excellence and leadership.
Skipping Breakfast May Compromise the Immune System
Mount Sinai study shows fasting can trigger a negative effect on fighting infection on a cellular level in mouse models
Bisexual Women Face Increased Risk of Heart Disease
Bisexual women were half as likely as their heterosexual peers to have high scores on a scale measuring cardiovascular health, new research from Columbia University School of Nursing shows.
Study Finds Chronically Disrupted Sleep May Increase the Risk for Heart Disease
Sleep irregularity — chronically disrupted sleep and highly variable sleep durations night after night — may increase the risk for atherosclerosis, according to a study led by Kelsie Full, PhD, MPH, of Vanderbilt University Medical Center.
Coconut Sugar May Lower Blood Pressure, Artery Stiffness in Older Adults
A first-of-its-kind study finds a natural coconut sugar may help reduce the risk of cardiovascular disease by improving blood vessel health and managing high blood pressure. The study is published ahead of print in the Journal of Applied Physiology.
Cleveland Clinic is offering “Galentine’s Day” e-card from American Greetings to raise money for research on heart disease, the #1 killer of women in the United States
Heart disease is the No. 1 killer of women and men in the United States. It causes one in every four U.S. deaths.
Survey: As early heart attacks increase, many young people may not consider their risks
February is American Heart Month and a new national survey commissioned by The Ohio State University Wexner Medical Center found that even though heart attacks are increasingly common in younger people, many don’t believe they are at risk for heart disease.
The survey – which was conducted online among more than 2,000 Americans age 18 and older – found 47% of those under age 45 don’t think they are at risk for heart disease.
The survey – which was conducted online among 2,082 Americans age 18 and older – found 53% of those age 18-34 and 38% of those age 35-44 don’t think they are at risk for heart disease.
Cardiologist to Female Patients: Be Aware of Atypical Heart Attack Symptoms
In recognition of American Heart Month (February), one cardiologist from New York Institute of Technology College of Osteopathic Medicine (NYITCOM) is sharing potentially life-saving information for patients assigned female at birth. “The leading killer in women is not cancer—it’s heart disease,…
This Groundbreaking Biomaterial Heals Tissues From the Inside Out
A new biomaterial that can be injected intravenously, reduces inflammation in tissue and promotes cell and tissue repair. The biomaterial was tested and proven effective in treating tissue damage caused by heart attacks in both rodent and large animal models. Researchers also provided proof of concept in a rodent model that the biomaterial could be beneficial to patients with traumatic brain injury and pulmonary arterial hypertension.
What is MINOCA? A Type of Heart Attack Mostly Affecting Women
Heart disease is the leading cause of death among women in the U.S., and a type of heart attack called myocardial infarction with non-obstructive coronary arteries (MINOCA), which predominantly affects women, is garnering increased attention.
Cancer Survivors may be at Risk for Heart Disease
The bottom line: before, during and after cancer treatment, heart health is critical. Andrew M. Evens, DO, MBA, MSc, associate director for Clinical Services at Rutgers Cancer Institute of New Jersey and medical director of the Oncology Service Line at RWJBarnabas Health, is a participating physician in the Cardio-Oncology Program at Rutgers Cancer Institute of New Jersey, the state’s leading cancer program, in partnership with RWJBarnabas Health, shares more on the topic.
Gum infection linked to increased risk of heart arrhythmia
Periodontitis, a gum disease, can lead to a litany of dental issues from bad breath to bleeding and lost teeth.
Keep Your Heart Strong with these 3 Foods. Expert Tips for February: American Hearth Month
Heart disease is the leading cause of death in the United States for both men and women, with half of all Americans (47%) qualifying for at least one of the three key risk factors (high blood pressure, high cholesterol, smoking cigarettes). Keep Your Heart Strong with these 3 Foods. Expert Tips for February: American Hearth Month
Heart disease is the leading cause of death in the United States for both men and women, with half of all Americans (47%) qualifying for at least one of the three key risk factors (high blood pressure, high cholesterol, smoking cigarettes). Good news: You can manage two of these risk factors.
Learn CPR and Lower Your Stress: Mount Sinai Cardiologists Emphasize Their Importance During American Heart Month
Doctors warn about lack of knowledge of administering CPR, especially in high-risk groups, and the rise of stress-related heart issues
Valentin Fuster, MD, PhD, Receives Prestigious Award from City of Barcelona, Spain
Mount Sinai Heart President given top honor for his extraordinary scientific achievements
Female and male hearts respond differently to stress hormone
Female and male hearts respond differently to “fight or flight” stress hormone, according to a new UC Davis study in mice. It may help explain sex differences in arrhythmia risk.
CTO Plus 2023 Will Feature Latest Research and Techniques for Chronic Total Occlusions and Complex PCI
CTO Plus 2023 will feature the latest research and techniques for chronic total occlusions (CTO) and complex percutaneous coronary interventions (PCI). The annual conference, organized by the Cardiovascular Research Foundation (CRF), will take place February 23-24 at the New York Marriott Marquis in New York, NY.
Researchers ID Protein That May Protect the Heart During Certain Cancer Treatment Regimens
Researchers identified a protein linked with the onset of anthracycline-associated cardiac toxicity. In two studies conducted in women undergoing treatment for breast cancer, levels of a protein known as hemopexin circulating in the blood were associated with increased cardiac toxicity.
Mouse study suggests new therapeutic strategy to reduce cardiovascular disease in cancer survivors
Researchers at Memorial Sloan Kettering Cancer Center (MSKCC) in New York have discovered that common cancer treatments, such as radiotherapy or anthracycline drugs, cause long-term damage to heart tissue by activating a key inflammatory signaling pathway. The study, published December 19 in the Journal of Experimental Medicine (JEM), suggests that inhibiting this pathway could reduce the chances of cancer survivors suffering heart disease later in life.
Albert Einstein College of Medicine and Montefiore Health System Receive $5.2 Million NIH Grant to Study Heart Failure in Hispanic Populations
Cardiology researchers at Albert Einstein College of Medicine and Montefiore Health System have received a five-year, $5.2 million grant from the National Institutes of Health (NIH) to explore the underlying causes of heart failure among Hispanics/Latinos, who are at heightened risk for heart disease. Investigators will take a novel approach to assess risk: by simultaneously evaluating heart function and the relationship between the heart and the aorta, the large artery that conveys oxygen-rich blood from the heart’s left ventricle to the rest of the body.
Parkinson’s medication improved blood pressure in teens with Type 1 diabetes
Teens with Type 1 diabetes (T1D) who took bromocriptine, a medication used to treat Parkinson’s disease and Type 2 diabetes, had lower blood pressure and less stiff arteries after one month of treatment compared to those who did not take the medicine, according to a small study published today in Hypertension, an American Heart Association journal.
Study: New tool twice as accurate at predicting antibody resistance among U.S. children with Kawasaki disease
A new tool under development by University at Buffalo researchers could one day help clinicians better predict resistance to immunoglobulin therapy among children with Kawasaki disease in the United States.
PET technology more effective than angiogram at determining need for coronary stents, bypass surgery
A new method for determining whether patients with heart disease need coronary stents or bypass surgery is more effective than the angiogram, which is currently used, according to research from UTHealth Houston Heart & Vascular.
Alexandra Popma, MD, Joins CRF as Executive Director of the CRF Clinical Trials Center
The Cardiovascular Research Foundation (CRF) announced today that Alexandra Popma, MD, has joined the organization as Executive Director of the CRF Clinical Trials Center.
Gender Affirmation Treatment Delivery Route May Affect Heart Health
Transgender and gender diverse (TGD) people assigned male at birth are at increased heart health risk. The delivery route of estrogen medication is known to affect heart health risk in cisgender women. However, research is lacking on how estrogen route affects heart health in the TGD population.
Restored blood flow meant less pain, better quality of life for those with leg artery disease
estoring blood flow to the legs, whether through bypass surgery or a less invasive artery-opening procedure with a stent, reduced pain and improved quality of life for people with peripheral artery disease (PAD), according to preliminary, late-breaking research presented today at the American Heart Association’s Scientific Sessions 2022.
Breast Cancer Survivorship Doubles
It was the information she couldn’t find that led Amy Kirkham, an assistant professor in the University of Toronto’s Faculty of Kinesiology & Physical Education (KPE), to her latest discovery.
Deepak L. Bhatt, MD, MPH, Named Director of Mount Sinai Heart
Will also serve as the first-ever Dr. Valentin Fuster Professor of Cardiovascular Medicine
Short bursts of vigorous activity linked with increased longevity
Two minute bursts of vigorous activity totalling 15 minutes a week are associated with a reduced risk of death, according to research published today in European Heart Journal, a journal of the European Society of Cardiology (ESC).1
Stroke, Clot Risk Halved in Heart Disease and Arrhythmia Patients Who Took Blood Thinners Apixaban Versus Rivaroxaban
The new study showed apixaban is superior to rivaroxaban against stroke or systemic embolism in patients with atrial fibrillation and valvular heart disease
Baltimore health fair offers free screenings, wellness activities for people with diabetes
Endocrine experts will deliver free health services in West Baltimore during EndoCares® Baltimore, an in-person health education event being held on November 5.
Valentin Fuster, MD, PhD, Named President of Mount Sinai Heart
Mount Sinai Health System’s globally acclaimed cardiologist Valentin Fuster, MD, PhD, has been named President of Mount Sinai Heart, a newly created position, effective Sunday, January 1, 2023. Dr. Fuster will continue in his roles as Physician-in-Chief of The Mount Sinai Hospital and as the Richard Gorlin, MD/Heart Research Foundation Professor at the Icahn School of Medicine at Mount Sinai.
Immune marker suPAR high in patients with heart failure, predicts risk and death
Levels of the immune protein suPAR are high in patients with heart failure and predict both heart failure and death, a new study suggests. Beyond that, when suPAR is combined with BNP, a downstream indicator of heart failure, the ability to predict such risks gets even stronger.
New survey: 91% of parents say their family is less stressed when they eat together
The American Heart Association releases new survey highlighting mealtime impact on mental well-being and introduces Together Tuesdays™ to help people maximize health benefits of shared meals.
Rate of food insecurity skyrockets for Americans with cardiovascular disease, study finds
The number of Americans with cardiovascular disease who are food insecure – having limited or uncertain access to adequate food – has more than doubled over the last 20 years, a national study finds. Adults with cardiovascular disease were more than two times likely to be food insecure than those without the cardiovascular disease.
AI-guided screening uses ECG data to detect a hidden risk factor for stroke
An AI-guided targeted screening strategy is effective in detecting new cases of atrial fibrillation that would not have come to attention in routine clinical care.
This strategy could reduce the number of undiagnosed cases of atrial fibrillation, and prevent stroke and death in millions of patients across the globe.
A Consistent Lack of Sleep Negatively Impacts Immune Stem Cells, Increasing Risk of Inflammatory Disorders and Heart Disease
Mount Sinai study also shows catching up on sleep doesn’t reverse possible negative effects on cellular level